Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 25 Cisplatin 17 pembrolizumab 6 Capecitabine 5 Fluorouracil 4 durvalumab 3 Taxes 3 Oxaliplatin 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 trametinib 2 pemigatinib 2 ivosidenib 2 infigratinib 2 derazantinib 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Nivolumab 2 Liver Transplantation 2 Leucovorin 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tucatinib 1 trifluridine tipiracil drug combination 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡